Header Logo

Connection

Kathleen Moore to Risk Assessment

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Risk Assessment.
Kathleen Moore
Connection Strength
0.097
Risk Assessment
  1. A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors. Clin Pharmacol Drug Dev. 2014 07; 3(4):284-9.
    View in: PubMed
    Score: 0.097
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.